Keywords: Novartis, Financial results, Fourth-quarter and full-year 2012

Novartis 4th-qtr sales rise 2% despite patent expiries

Article | 23 January 2013

Swiss drug major Novartis (NOVN: VX) posted fourth-quarter and full-year 2012 financial results this morning revealing that group sales for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing